HC Wainwright Issues Negative Estimate for DRUG Earnings
Research analysts at HC Wainwright decreased their Q3 2025 earnings estimates for shares of Bright Minds Biosciences in a ...
What is HC Wainwright’s Forecast for LPTH FY2025 Earnings?
HC Wainwright dropped their FY2025 earnings estimates for shares of LightPath Technologies in a report released on Tuesday, February 18th. HC Wainwright analyst S. Buck now expects that the technology ...
H.C. Wainwright says SEC plan to dismiss suit lifts ‘major overhang’ on Coinbase
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
H.C. Wainwright Sticks to Its Hold Rating for Biotricity (BTCY)
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Biotricity (BTCY – Research Report) today. The company’s shares closed yesterday ...
MyChesCo on MSN3d
Michael Klichinsky to Speak at H.C. Wainwright Cell Therapy Virtual Conference
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that Michael Klichinsky, PharmD, PhD, Co-founder ...